Title |
Personalized Risk Assessment of Drug-Related Harm Is Associated with Health Outcomes
|
---|---|
Published in |
PLOS ONE, November 2013
|
DOI | 10.1371/journal.pone.0079754 |
Pubmed ID | |
Authors |
Andrea A. Jones, Fidel Vila-Rodriguez, William J. Panenka, Olga Leonova, Verena Strehlau, Donna J. Lang, Allen E. Thornton, Hubert Wong, Alasdair M. Barr, Ric M. Procyshyn, Geoffrey N. Smith, Tari Buchanan, Mel Krajden, Michael Krausz, Julio S. Montaner, G. William MacEwan, David J. Nutt, William G. Honer |
Abstract |
The Independent Scientific Committee on Drugs (ISCD) assigned quantitative scores for harm to 20 drugs. We hypothesized that a personalized, ISCD-based Composite Harm Score (CHS) would be associated with poor health outcomes in polysubstance users. |
X Demographics
The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 4 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 4 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 58 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 2% |
Unknown | 57 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 10 | 17% |
Student > Ph. D. Student | 10 | 17% |
Researcher | 7 | 12% |
Student > Doctoral Student | 5 | 9% |
Student > Bachelor | 3 | 5% |
Other | 12 | 21% |
Unknown | 11 | 19% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 13 | 22% |
Psychology | 12 | 21% |
Biochemistry, Genetics and Molecular Biology | 4 | 7% |
Social Sciences | 3 | 5% |
Pharmacology, Toxicology and Pharmaceutical Science | 2 | 3% |
Other | 9 | 16% |
Unknown | 15 | 26% |